The scientific content of this meeting is extraordinary. The richness of the program is a testament to the vibrancy of the College as well as the hard work of the Program Committee. The Committee was overwhelmed with exceptional proposals, and had to make difficult decisions. I am particularly grateful to Larry Siever for chairing the Program Committee, and Robbie Schwarcz his co-chair, for guiding the Committee and ultimately producing so strong and diverse a program. In my initial letter to the membership, I encouraged submissions that elaborated on new targets for drug development and new theories of pathophysiology. I am pleased that the membership responded to this request and the program reflects the elaboration of these themes.
For the last three years Neuropyschopharmacology, our College's official journal, has been publishing the abstracts of the meeting. Consequently these abstracts have been citable and are archival. The decision to move these abstracts from their previously internal audience to the wider archival audience is a decision with far reaching consequences, and thus one that was first taken by ACNP leadership after serious deliberation and only on a pilot basis. We would encourage your input as to whether publication of our abstracts in Neuropyschopharmacology should continue.
We find ourselves in a new venue this year. As our meeting has grown, fewer and fewer sites are able to accommodate all our needs. Our College has prided itself in its encouragement of informality and collegiality in its annual meetings, a goal that is facilitated by accommodations that are consolidated. We are hopeful that our new venue will maximize our comfort and scientific exchange.
